Home
About
Publications Trends
Recent Publications
Expert Search
Archive
brca1 or brca2
Are there lifestyle changes that can reduce the risk of BRCA-related cancers?
While genetic predisposition plays a significant role, lifestyle factors can also influence cancer risk. Some recommendations include:
- Regular physical activity.
- Maintaining a healthy weight.
- Limiting alcohol intake.
- Avoiding tobacco use.
- Eating a balanced, nutritious diet.
Frequently asked queries:
How do BRCA1 and BRCA2 mutations contribute to cancer?
Who should get tested for BRCA1 and BRCA2?
What are the therapeutic options for BRCA-related cancers?
Are there lifestyle changes that can reduce the risk of BRCA-related cancers?
What is the role of genetic counseling?
What are other cancers associated with BRCA1 and BRCA2 mutations?
What is the future of BRCA1 and BRCA2 research?
Why is Cardiotoxicity Important in Cancer Treatment?
Why is Personal Connection Important in Cancer Care?
What Are the Challenges in Targeting Beclin 1?
What Challenges Contribute to Limited Penetration Depth?
What is Ginger?
What are the Common Symptoms of irAEs?
What is Limited Evidence in Cancer Research?
What is a Medical Oncology Fellowship?
What is Chronic Pulmonary Disease?
What are Targeted Treatments?
How Does SEER Impact Cancer Research?
Can You Get Cancer Insurance After a Diagnosis?
What is Chemotherapy Induced Neuropathy?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe